ALACHUA, Fla.–(BUSINESS WIRE)–Nanotherapeutics, Inc., a global manufacturer of biodefense and infectious disease products, announced today that it has received two new Task Orders from The United States Department of Health and Human Services (HHS), Biomedical Advanced Research and Development Authority (BARDA) Fill-Finish Manufacturing Network’s (FFMN) Pilot Production program, for the Center for Drug Evaluation and Research (CDER) pathway regulated products.

Read Full Article at BUSINESSWIRE

 

 

2015-07-10T09:36:44+00:00 July 10th, 2015|